These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27655518)

  • 1. Probiotic mixture supplementation in the preventive management of trinitrobenzenesulfonic acid-induced inflammation in a murine model.
    Traina G; Menchetti L; Rappa F; Casagrande-Proietti P; Barbato O; Leonardi L; Carini F; Piro F; Brecchia G
    J Biol Regul Homeost Agents; 2016; 30(3):895-901. PubMed ID: 27655518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactobacillus casei and bifidobacterium lactis supplementation reduces tissue damage of intestinal mucosa and liver after 2,4,6-trinitrobenzenesulfonic acid treatment in mice.
    Bellavia M; Rappa F; Lo Bello M; Brecchia G; Tomasello G; Leone A; Spatola G; Uzzo ML; Bonaventura G; David S; Damiani P; Hajj Hussein I; Zeenny MN; Jurjus A; Schembri-Wismayer P; Cocchi M; Zummo G; Farina F; Gerbino A; Cappello F; Traina G
    J Biol Regul Homeost Agents; 2014; 28(2):251-61. PubMed ID: 25001657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes.
    Roselli M; Finamore A; Nuccitelli S; Carnevali P; Brigidi P; Vitali B; Nobili F; Rami R; Garaguso I; Mengheri E
    Inflamm Bowel Dis; 2009 Oct; 15(10):1526-36. PubMed ID: 19504616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with synbiotic Syngut on experimental colitis under stress conditions.
    Konturek PC; Konturek K; Brzozowski T; Wojcik D; Magierowski M; Targosz A; Krzysiek-Maczka G; Sliwowski Z; Strzalka M; Magierowska K; Szczyrk U; Kwiecien S; Ptak-Belowska A; Neurath M; Dieterich W; Wirtz S; Zopf Y
    J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bifidobacterium longum and VSL#3
    Chen X; Fu Y; Wang L; Qian W; Zheng F; Hou X
    Dev Comp Immunol; 2019 Mar; 92():77-86. PubMed ID: 30227219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis.
    Peran L; Camuesco D; Comalada M; Bailon E; Henriksson A; Xaus J; Zarzuelo A; Galvez J
    J Appl Microbiol; 2007 Oct; 103(4):836-44. PubMed ID: 17897185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive effects of bovine colostrum supplementation in TNBS-induced colitis in mice.
    Filipescu IE; Leonardi L; Menchetti L; Guelfi G; Traina G; Casagrande-Proietti P; Piro F; Quattrone A; Barbato O; Brecchia G
    PLoS One; 2018; 13(8):e0202929. PubMed ID: 30138385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactobacillus fermentum CECT 5716 prevents and reverts intestinal damage on TNBS-induced colitis in mice.
    Mañé J; Lorén V; Pedrosa E; Ojanguren I; Xaus J; Cabré E; Domènech E; Gassull MA
    Inflamm Bowel Dis; 2009 Aug; 15(8):1155-63. PubMed ID: 19266568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis.
    Peran L; Camuesco D; Comalada M; Nieto A; Concha A; Diaz-Ropero MP; Olivares M; Xaus J; Zarzuelo A; Galvez J
    World J Gastroenterol; 2005 Sep; 11(33):5185-92. PubMed ID: 16127750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent Effectiveness of Multispecies Probiotic Preparations on Intestinal Microbiota Structure Depends on Metabolic Properties.
    Biagioli M; Capobianco D; Carino A; Marchianò S; Fiorucci C; Ricci P; Distrutti E; Fiorucci S
    Nutrients; 2019 Feb; 11(2):. PubMed ID: 30717413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model.
    del Carmen S; Martín Rosique R; Saraiva T; Zurita-Turk M; Miyoshi A; Azevedo V; de Moreno de LeBlanc A; Langella P; Bermúdez-Humarán LG; LeBlanc JG
    J Clin Gastroenterol; 2014; 48 Suppl 1():S12-7. PubMed ID: 25291117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the benefit of whey-cultured Lactobacillus casei in murine colitis.
    Ghasemi-Niri SF; Abdolghaffari AH; Fallah-Benakohal S; Hosseinpour-Feizi M; Mahdaviani P; Jamalifar H; Baeeri M; Dehghan G; Abdollahi M
    J Physiol Pharmacol; 2011 Jun; 62(3):341-6. PubMed ID: 21893695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches.
    Alard J; Peucelle V; Boutillier D; Breton J; Kuylle S; Pot B; Holowacz S; Grangette C
    Benef Microbes; 2018 Feb; 9(2):317-331. PubMed ID: 29488412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri.
    Gao C; Major A; Rendon D; Lugo M; Jackson V; Shi Z; Mori-Akiyama Y; Versalovic J
    mBio; 2015 Dec; 6(6):e01358-15. PubMed ID: 26670383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations.
    Drouault-Holowacz S; Foligné B; Dennin V; Goudercourt D; Terpend K; Burckel A; Pot B
    Clin Nutr; 2006 Dec; 25(6):994-1003. PubMed ID: 16698150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics.
    Mariman R; Kremer B; van Erk M; Lagerweij T; Koning F; Nagelkerken L
    Inflamm Bowel Dis; 2012 Aug; 18(8):1424-33. PubMed ID: 22162025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice.
    Mendes MCS; Paulino DS; Brambilla SR; Camargo JA; Persinoti GF; Carvalheira JBC
    World J Gastroenterol; 2018 May; 24(18):1995-2008. PubMed ID: 29760543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactobacillus reuteri 5454 and Bifidobacterium animalis ssp. lactis 5764 improve colitis while differentially impacting dendritic cells maturation and antimicrobial responses.
    Hrdý J; Alard J; Couturier-Maillard A; Boulard O; Boutillier D; Delacre M; Lapadatescu C; Cesaro A; Blanc P; Pot B; Ryffel B; Chamaillard M; Grangette C
    Sci Rep; 2020 Mar; 10(1):5345. PubMed ID: 32210304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partially hydrolysed guar gum ameliorates murine intestinal inflammation in association with modulating luminal microbiota and SCFA.
    Takagi T; Naito Y; Higashimura Y; Ushiroda C; Mizushima K; Ohashi Y; Yasukawa Z; Ozeki M; Tokunaga M; Okubo T; Katada K; Kamada K; Uchiyama K; Handa O; Itoh Y; Yoshikawa T
    Br J Nutr; 2016 Oct; 116(7):1199-1205. PubMed ID: 27604176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation.
    Biagioli M; Carino A; Di Giorgio C; Marchianò S; Bordoni M; Roselli R; Distrutti E; Fiorucci S
    Nutrients; 2020 Jun; 12(7):. PubMed ID: 32629887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.